Hot Life Science Investor Mandate 3: European VC Firm with New Fund Seeking Broad Range of Medical Devices Throughout the US and EU

26 Mar

A European VC firm with over €700 million in total assets under management, and has raised a total of five funds; the most recent fund closed in 2014. The firm typically invests €1-5 million in venture-stage opportunities, or up to €15 million in growth-stage opportunities.  The firm is open to opportunities globally and has invested in Western and Eastern Europe, the Middle East and the USA.

Within the life science sector the firm is currently focused on medical technology, diagnostics, life science tools, and digital health. The firm is open to all classes of devices and molecules, is open to opportunities in any indication area and at any phase of development.  Previous investments include diagnostics for stroke, nano coatings for implants, and cardiovascular catheters.

The firm is open to investing in pre-revenue companies, companies at the early commercialization stage, as well companies generating steady revenues.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: